DNA Aptamer against Acute Lymphoblastic Leukemia (ALL) Cancer Cells

DNA Aptamer against Acute Lymphoblastic Leukemia (ALL) Cancer Cells

$249.00$629.00

DNA aptamer against acute lymphoblastic leukemia (ALL) cells

SKU: APT-067 Category:

Background

Leukemia is a group of blood cancers that usually begin in the bone marrow and produce high numbers of abnormal blood cells. These blood cells are not fully developed and are called blasts or leukemia cells. There are four main types of leukemia

  • Acute lymphoblastic leukemia (ALL).
  • Acute myeloid leukemia (AML).
  • Chronic lymphocytic leukemia (CLL).
  • Chronic myeloid leukemia (CML).

Diagnosis is typically made by blood tests or bone marrow biopsy.

Fusion BioLabs provides validated DNA aptamer against acute lymphoblastic leukemia (ALL) cells.

 

Product Specification

Aptamer type: DNA aptamer

Aptamer length: 51 bp

Affinity KD: 5.16 nM by Cell-SELEX

Storage: keep at -20°C. DNA aptamers are guaranteed stable for 12 months when properly stored.

Weight 0.5 lbs
Dimensions 1 × 1 × 1 in
Size

10 nmol, 30 nmol

DOCUMENTATION

Data Sheet

Aptamer Development Services

Nucleic Acid AptamersFind Better Aptamers using Structured Aptamer LibrariesLearn More
Magnetic beads-based SELEXFind DNA/RNA Aptamers against Targets Immobilized on Magnetic BeadsLearn More
Capture-SELEXFind DNA/RNA Aptamers Using Immobilized Aptamer LibraryLearn More
Cell-SELEXIdentify either Cell-Surfaced or Cell-Internalized DNA/RNA Aptamers Learn More
Peptide AptamersIdentify Peptide Aptamers Using Beads-Based Phage Panning PlatformLearn More
Aptamer-based Biomarker DiscoveryDiscover Biomarkers Using Aptamer-Facilitated PlatformsLearn More